Detection and characterization of DNA variants in the promoter regions of hundreds of human disease candidate genes

Genomics

Volumn 87, Issue 6, 2006, Pages 704-710

  Sinnett, Daniel ^a,b   Beaulieu, Patrick ^a   Bélanger, Hélène ^a   Lefebvre, Jean François ^a   Langlois, Sylvie ^a   Théberge, Marie Christine ^a   Drouin, Simon ^a   Zotti, Corinne ^c   Hudson, Thomas J ^c   Labuda, Damian ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Complex diseases; Genomics; Promoter polymorphisms; Regulatory genetics

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DINUCLEOTIDE REPEAT; DNA DETERMINATION; DNA SEQUENCE; GENE TARGETING; GENETIC SCREENING; GENETIC VARIABILITY; GENOME; HUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION SITE;

BINDING SITES; DNA; GENETIC DISEASES, INBORN; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; VARIATION (GENETICS);

EID: 33646844960     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2006.01.001     Document Type: Article

References (50)

1. Yasuda T., et al. The molecular basis for genetic polymorphism of human deoxyribonuclease II (DNase II): a single nucleotide substitution in the promoter region of human DNase II changes the promoter activity. FEBS Lett. 467 (2000) 231-234
2. Li L.C., et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res. 60 (2000) 873-876
3. Smeraldi E., et al. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol. Psychiatry 3 (1998) 508-511
4. Sanak M., Pierzchalska M., Bazan-Socha S., and Szczeklik A. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am. J. Respir. Cell Mol. Biol. 23 (2000) 290-296
5. Manuck S.B., Flory J.D., Ferrell R.E., Mann J.J., and Muldoon M.F. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res. 95 (2000) 9-23
6. Pihlajamaki J., et al. G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1789-1795
7. Ishigami T., et al. Angiotensinogen gene polymorphism near transcription start site and blood pressure: role of a T-to-C transition at intron I. Hypertension 34 (1999) 430-434
8. Pastinen T., and Hudson T.J. Cis-acting regulatory variation in the human genome. Science 306 (2004) 647-650
9. King M.C., and Wilson A.C. Evolution at two levels in humans and chimpanzees. Science 188 (1975) 107-116
10. Enard W., et al. Intra- and interspecific variation in primate gene expression patterns. Science 296 (2002) 340-343
11. Pastinen T., et al. A survey of genetic and epigenetic variation affecting human gene expression. Physiol. Genom. 16 (2004) 184-193
12. Lo H.S., et al. Allelic variation in gene expression is common in the human genome. Genome Res. 13 (2003) 1855-1862
13. Yan H., Yuan W., Velculescu V.E., Vogelstein B., and Kinzler K.W. Allelic variation in human gene expression. Science 297 (2002) 1143
14. Rockman M.V., and Wray G.A. Abundant raw material for cis-regulatory evolution in humans. Mol. Biol. Evol. 19 (2002) 1991-2004
15. Hellmann I., et al. Selection on human genes as revealed by comparisons to chimpanzee cDNA. Genome Res. 13 (2003) 831-837
16. Labuda D., and Striker G. Sequence conservation in Alu evolution. Nucleic Acids Res. 17 (1989) 2477-2491
17. Kondrashov A.S. Direct estimates of human per nucleotide mutation rates at 20 loci causing Mendelian diseases. Hum. Mutat. 21 (2003) 12-27
18. Tomso D.J., and Bell D.A. Sequence context at human single nucleotide polymorphisms: overrepresentation of CpG dinucleotide at polymorphic sites and suppression of variation in CpG islands. J. Mol. Biol. 327 (2003) 303-308
19. Watterson G.A. On the number of segregating sites in genetical models without recombination. Theor. Popul. Biol. 7 (1975) 256-276
20. Freudenberg-Hua Y., et al. Single nucleotide variation analysis in 65 candidate genes for CNS disorders in a representative sample of the European population. Genome Res. 13 (2003) 2271-2276
21. Cargill M. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 22 (1999) 231-238
22. Wong G.K., et al. A population threshold for functional polymorphisms. Genome Res. 13 (2003) 1873-1879
23. Fan J.B., et al. Assessing DNA sequence variations in human ESTs in a phylogenetic context using high-density oligonucleotide arrays. Genomics 80 (2002) 351-360
24. Zhang Z., and Gerstein M. Of mice and men: phylogenetic footprinting aids the discovery of regulatory elements. J. Biol. 2 (2003) 11
25. Mottagui-Tabar S., et al. Identification of functional SNPs in the 5-prime flanking sequences of human genes. BMC Genet. 6 (2005) 18-27
26. Ashburner M., et al. Gene Ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25 (2000) 25-29
27. Richman A. Evolution of balanced genetic polymorphism. Mol. Ecol. 9 (2000) 1953-1963
28. Coleman S.L., et al. Experimental analysis of the annotation of promoters in the public database. Hum. Mol. Genet. 11 (2002) 1817-1821
29. Rogozin I., Kondrashov F., and Glazko G. Use of mutation spectra analysis software. Hum. Mutat. 17 (2001) 83-102
30. Rogozin I.B., and Pavlov Y.I. Theoretical analysis of mutation hotspots and their DNA sequence context specificity. Mutat. Res. 544 (2003) 65-85
31. Miller J.H. Mutational specificity in bacteria. Annu. Rev. Genet. 17 (1983) 215-238
32. Krawczak M., Ball E.V., and Cooper D.N. Neighboring-nucleotide effects on the rates of germ-line single-base-pair substitution in human genes. Am. J. Hum. Genet. 63 (1998) 474-488
33. Herniou E., et al. Retroviral diversity and distribution in vertebrates. J. Virol. 72 (1998) 5955-5966
34. Brosius J. RNAs from all categories generate retrosequences that may be exapted as novel genes or regulatory elements. Gene 238 (1999) 115-134
35. Yoder J.A., Walsh C.P., and Bestor T.H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13 (1997) 335-340
36. Kel A., Kel-Margoulis O., Babenko V., and Wingender E. Recognition of NFATp/AP-1 composite elements within genes induced upon the activation of immune cells. J. Mol. Biol. 288 (1999) 353-376
37. Klingenhoff A., Frech K., Quandt K., and Werner T. Functional promoter modules can be detected by formal models independent of overall nucleotide sequence similarity. Bioinformatics 15 (1999) 180-186
38. Frech K., Danescu-Mayer J., and Werner T. A novel method to develop highly specific models for regulatory units detects a new LTR in GenBank which contains a functional promoter. J. Mol. Biol. 270 (1997) 674-687
39. Fickett J.W. Coordinate positioning of MEF2 and myogenin binding sites. Gene 172 (1996) GC19-GC32
40. GuhaThakurta D., and Stormo G.D. Identifying target sites for cooperatively binding factors. Bioinformatics 17 (2001) 608-621
41. Duret L., and Bucher P. Searching for regulatory elements in human noncoding sequences. Curr. Opin. Struct. Biol. 7 (1997) 399-406
42. Dermitzakis E.T., and Clark A.G. Evolution of transcription factor binding sites in mammalian gene regulatory regions: conservation and turnover. Mol. Biol. Evol. 19 (2002) 1114-1121
43. Chuang J.H., and Li H. Functional bias and spatial organization of genes in mutational hot and cold regions in the human genome. PLoS Biol. 2 (2004) E29
44. Akey J.M., Zhang G., Zhang K., Jin L., and Shriver M.D. Interrogating a high-density SNP map for signatures of natural selection. Genome Res. 12 (2002) 1805-1814
45. Underhill P.A., et al. Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography. Genome Res. 7 (1997) 996-1005
46. Ewing B., Hillier L., Wendl M.C., and Green P. Base-calling of automated sequencer traces using phred: I. Accuracy assessment. Genome Res. 8 (1998) 175-185
47. Vasiliev G.V., et al. Point mutations within 663-666 bp of intron 6 of the human TDO2 gene, associated with a number of psychiatric disorders, damage the YY-1 transcription factor binding site. FEBS Lett. 462 (1999) 85-88
48. Boccia L.M., Lillicrap D., Newcombe K., and Mueller C.R. Binding of the Ets factor GA-binding protein to an upstream site in the factor IX promoter is a critical event in transactivation. Mol. Cell. Biol. 16 (1996) 1929-1935
49. Knight J.C., et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat. Genet. 22 (1999) 145-150
50. Piedrafita F.J., et al. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem. 271 (1996) 14412-14420